📰 Depression Scale News
Page 5 - Depression Scale News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Depression Scale. Real-time updates on events, politics, business and more.
November 3, 2023
Researchers collected demographic, psychological, and clinical data perioperatively and assessed patients for chronic post-surgical pain.
October 31, 2023
The odds of being screened for anxiety and depression as a cardiac rehabilitation patient were significantly decreased during the pandemic.
October 27, 2023
The odds of being screened for anxiety and depression as a cardiac rehabilitation patient were significantly decreased during the pandemic.
October 24, 2023
Switching from biosimilar CT-P13 to SB2 is safe and effective, according to new research. The patients in the study had no significant changes in their psychometric assessments during the 12 month follow up.
October 19, 2023
In vitro fertilization (IVF) is a time-intensive and often stress-inducing fertility procedure. Yet how does that stress impact its success? Investigators at Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, assessed the effects of anxiety and depression in men on fertility and IVF outcomes.
October 19, 2023
<p>.In vitro fertilization (IVF) is a time-intensive and often stress-inducing fertility procedure. Yet how does that stress impact its success? Investigators at <a href="https://www.brighamandwomens.org/">Brigham and Women&rsquo;s Hospital</a>, a founding member of the <a href="https://www.massgeneralbrigham.org/">Mass General Brigham</a> healthcare system, assessed the effects of anxiety and depression in men on fertility and IVF outcomes&l...
October 18, 2023
Results from the phase 3 ATLANTIS study showed amitriptyline was superior to placebo across multiple symptom-based outcomes for patients with IBS.
October 16, 2023
Meta-analysis findings show that GLP-1 receptor agonists significantly reduced depressive symptoms for individuals with type 2 diabetes.
October 11, 2023
Meta-analysis findings show that GLP-1 receptor agonists significantly reduced depressive symptoms for individuals with type 2 diabetes.
October 10, 2023
Meta-analysis findings show that GLP-1 receptor agonists significantly reduced depressive symptoms for individuals with type 2 diabetes.